Zero2IPO
VC Fund
Beijing, China
Zero2IPO is a VC fund in Beijing focused on Education and Biotechnology. Founded in 1999, Zero2IPO is a leading integrated service provider in the China venture capital and private equity industry. Now, Zero2IPO has become an unbeatable dealflow and networking source in China. Zero2IPO's mission is to be the preferred service provider to businesses in the venture capital and private equity industry by offering anunparalleled knowledge and expertise to our clients and partners. To ensure this, Zero2IPO provides a broad and deep array of services enabling entrepreneurs and investors to reach the next level of success.Zero2IPO Group is headquartered in Beijing with offices in Shanghai, Shenzhen, Hong Kong, and Silicon Valley.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 32%
Last updated:
For AI agents: llms.txt
Industries Zero2IPO invests in
Stages Zero2IPO invests in
Countries Zero2IPO invests in
Round sizes
Contacts
Round size
- Seed
- $2.2M–$15M
- Angel
- $425k–$15M
- Series A
- $3.1M–$25M
Investment Focus
Industry
- Education 7 (17%)
- Biotechnology 6 (15%)
- Manufacturing 6 (15%)
- Information Technology 4 (10%)
- Artificial Intelligence 4 (10%)
Stage
- Series A 15 (37%)
- Angel 7 (17%)
- Seed 6 (15%)
- Series B 5 (12%)
- Series C 4 (10%)
Country
- China 35 (85%)
- United States 2 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Gavin Ni
Founder, Chairman & Chief Executive Officer
|
Founder, Chairman & Chief Executive Officer | Total investments: 0 | Find email | |
|
Liu Yada
Investment Director
|
Investment Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Violoop
|
Violoop is a Chinese AI hardware startup Specializes in AI-PC automation hardware as a "physical-level AI Operator", bridging legacy software and AI agents for 24/7 workflows without APIs. | $14.9M / Seed / Sep 01, 2026 | |
Coremins
|
Coremins is a full-service provider of lithium battery HSI high shear insulating material spraying solutions. | $14.7M / Series A / Jul 10, 2026 | |
|
StarNuclear Fusion
|
StarNuclear Fusion is focused on the "high-temperature superconductivity + advanced quasi-isotropic propulsion (QI)" stellarator technology roadmap. | $122.3M / Series A / Jun 30, 2026 | |
| SpinQ Technology develops superconducting chip quantum computers, desktop nuclear magnetic resonance quantum computers, and quantum computing-related software. | $147.2M / Series D / Jun 30, 2026 | ||
Topband Huachuang
|
Topband is a membrane material technology developer, mainly engaged in the research and development of special separation membrane materials. Its products are widely used in new energy, semiconductor, coal chemical and other fields. | $14.7M / Series C / May 26, 2026 | |
| SPERIKON is an innovative biotechnology company focusing on liquid reagents in cell biology. It is deeply involved in core scenarios such as cell biology research, cell medicine and drug development, cell health industry, and cell aesthetic medicine. With technological breakthroughs and industrialization capabilities, it provides high-qualityreagent products and full-chain services to the global cell biology field, promoting cell technology from the laboratory to clinical application and industrial implementation. | $14.7M / Series A / May 24, 2026 | ||
| FemtoMed is a developer of femtosecond laser treatment systems for ophthalmology, focusing on the clinical translation of femtosecond lasers in ophthalmic surgery. | $14.7M / Angel / Apr 19, 2026 | ||
| Shunheng Intelligence focus on robotic technologies. | Angel / Mar 11, 2026 | ||
| Ruidong New Energy provides power systems for new energy and electric vehicles. The company specializes in the design and manufacture of power systems for new energy and energy-efficient automobiles. | Series A / Feb 06, 2026 | ||
| Huasai Biotechnology develops microbial production of nucleotide-related raw materials utilizing synthetic biology technology. | $14.3M / Series A / Jan 04, 2026 | ||
| See all 41 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Zero2IPO invest in?
Zero2IPO invests primarily in Education, Biotechnology and Manufacturing startups, most often at Series A and Angel stage. Most of the 41 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Zero2IPO's check size?
Zero2IPO typically joins rounds of $2.2M–$15M at Seed, $425k–$15M at Angel and $3.1M–$25M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Zero2IPO participates in.
How do I contact Zero2IPO?
Public channels for Zero2IPO include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Zero2IPO?
The team at Zero2IPO includes Gavin Ni (Founder, Chairman & Chief Executive Officer) and Liu Yada (Investment Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
